Order this book!

This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Cited by other online articles PubMed PubMed Citation Articles by Dalakas, M. C.

Annals of the New York Academy of Sciences, Vol 753, Issue 1 68-80, Copyright © 1995 by New York Academy of Sciences

ARTICLES

The post-polio syndrome as an evolved clinical entity. Definition and clinical description

M. C. Dalakas
Medical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA.

Post-polio syndrome (PPS) refers to the new neuromuscular symptoms that occur at least 15 years after stability in patients with prior acute paralytic polio-myelitis. They include: (1) new muscle weakness and atrophy in the limbs, the bulbar or the respiratory muscles [post-poliomyelitis muscular atrophy (PPMA)] and (2) excessive muscle fatigue and diminished physical endurance. PPS is a clinical diagnosis that requires exclusion of all other medical, neurological, orthopedic or psychiatric diseases that could explain the cause of the new symptoms. Routine electromyography is useful to confirm chronic and ongoing denervation and exclude neuropathies. Muscle biopsy, single fiber electromyography (EMG), macro-EMG, serum antibody titers to polio virus, and spinal fluid studies are very useful research tools but they are rarely needed to establish the clinical diagnosis. PPS is a slowly progressive phenomenon with periods of stability that vary from 3 to 10 years. Current evidence indicates that PPS is the evolution of a subclinically ongoing motor neuron dysfunction that begins after the time of the acute polio. It is clinically manifested as PPS when the well-compensated reinnervating process crosses a critical threshold beyond which the remaining motor neurons cannot maintain the innervation to all the muscle fibers within their motor unit territory.

This article has been cited by other articles:

				A.-S. Gosselin, Y. Simonin, F. Guivel-Benhassine, V. Rincheval, J.-L. Vayssiere, B. Mignotte, F. Colbere-Garapin, T. Couderc, and B. Blondel Poliovirus-Induced Apoptosis Is Reduced in Cells Expressing a Mutant CD155 Selected during Persistent Poliovirus Infection in Neuroblastoma Cells J. Virol., December 6, 2002; 77(1): 790 - 798. [Abstract] [Full Text] [PDF]

				H. Siegel, C. McCutchen, M. C. Dalakas, A. Freeman, B. Graham, D. Alling, and S. Sato Physiologic events initiating REM sleep in patients with the postpolio syndrome Neurology, February 1, 1999; 52(3): 516 - 516. [Abstract] [Full Text] [PDF]

				R. D. Madison, S. J. Archibald, R. Lacin, and C. Krarup Factors Contributing to Preferential Motor Reinnervation in the Primate Peripheral Nervous System J. Neurosci., December 15, 1999; 19(24): 11007 - 11016. [Abstract] [Full Text]